Shu Peng
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer （Radiogenomics-Esophagus） (NCT07354295) | Shu Peng | 2025-07-26 |
Track Shu Peng automatically
Every clearance here is in the API, with alerts when new ones post.